Her copy & pasted Kurabayashi discussion is irreconcilable with the rest of her opinion.
With infringement, secondary considerations, etc. she compares both parties' arguments, and with her own analysis explains her decision. And all that hard work for naught because ctrl c ctrl v with generics' ApoB crap.
Market Data 
Markets 
AI
